The University of Notre Dame Australia

ResearchOnline@ND
Nursing Papers and Journal Articles

School of Nursing

2020

Delirium point prevalence studies in inpatient settings: A systematic review
Binu Koirala
Bryan R. Hansen
Annmarie Hosie
The University of Notre Dame Australia, annmarie.hosie1@nd.edu.au

Chakra Budhathoki
Stella Seal

See next page for additional authors

Follow this and additional works at: https://researchonline.nd.edu.au/nursing_article
Part of the Nursing Commons
This article was originally published as:
Koirala, B., Hansen, B. R., Hosie, A., Budhathoki, C., Seal, S., Beaman, A., & Davidson, P. M. (2020). Delirium point prevalence studies
in inpatient settings: A systematic review. Journal of Clinical Nursing, Early View, Online First.
Original article available here:
10.1111/jocn.15219

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/nursing_article/157. For more
information, please contact researchonline@nd.edu.au.

Authors
Binu Koirala, Bryan R. Hansen, Annmarie Hosie, Chakra Budhathoki, Stella Seal, Adam Beaman, and
Patricia M. Davidson

This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/nursing_article/157

Copyright ©2020 John Wiley & Sons Ltd. All rights reserved.
This is the peer reviewed version of the following article:
Koirala, B., Hansen, B.R., Hosie, A., Budhathoki, C., Seal, S., Beaman, A., and Davidson, P.M.
(2020). Delirium point prevalence studies in inpatient settings: A systematic review and
meta-analysis. Journal of Clinical Nursing, Early View Online First, doi: 10.1111/jocn.15219
This article has been published in final form at: https://doi.org/10.1111/jocn.15219

This article may be used for non-commercial purposes in accordance with Wiley Terms and
Conditions for self-archiving.

DELIRIUM POINT PREVALENCE: REVIEW & META-ANALYSIS

1

Delirium Point Prevalence Studies in Inpatient Settings: A Systematic Review and Metaanalysis
Binu Koirala, PhD, MGS, RN,1 Bryan R. Hansen, PhD, RN, APRN-CNS, ACNS-BC,1
Annmarie Hosie, PhD, RN2, Chakra Budhathoki, PhD1, Stella Seal, MLS3, Adam Beaman,
MPH,1,2 Patricia M. Davidson, PhD, MEd, RN, FAAN1,2
1

Johns Hopkins School of Nursing

2

University of Technology Sidney

3

Welch Medical Library, Johns Hopkins University & Medicine

Binu Koirala, PhD, MGS, RN (corresponding author)
Research Associate
Johns Hopkins School of Nursing
525 North Wolfe Street
Baltimore, Maryland, 21205
Office: 410-614-4718
Email: bkoiral1@jhu.edu
Bryan R. Hansen, PhD, RN, APRN-CNS, ACNS-BC
Assistant Professor
Johns Hopkins School of Nursing
525 North Wolfe Street
Baltimore, Maryland, 21205
Office: 410-614-4820
Email: bhansen3@jhu.edu
Annmarie Hosie, PhD, RN
Associate Professor, Palliative Care Nursing

DELIRIUM POINT PREVALENCE: REVIEW & META-ANALYSIS
School of Nursing Sydney
The University of Notre Dame Australia
160 Oxford Street, Darlinghurst, NSW 2010
Office: +61 2 8204 4275
Email: annmarie.hosie1@nd.edu.au
Chakra Budhathoki, PhD
Associate Professor
Johns Hopkins School of Nursing
525 North Wolfe Street
Baltimore, Maryland, 21205
Office: 410-614-5320
Email: cbudhat1@jhu.edu
Stella Seal, MLS
Library Operation Manager
Johns Hopkins University and Medicine Welch Medical Library
1900 East Monument Street
Baltimore, Maryland, 21205
Email: sms@jhmi.edu
Adam Beaman, MPH
Sr. Associate Strategic Initiatives
Johns Hopkins School of Nursing & University of Technology Sydney
525 North Wolfe Street
Baltimore, Maryland, 21205
Email: abeaman1@jhu.edu
Patricia M. Davidson, PhD, MEd, RN, FAAN

2

DELIRIUM POINT PREVALENCE: REVIEW & META-ANALYSIS

3

Dean and Professor
Johns Hopkins School of Nursing & University of Technology Sydney
525 North Wolfe Street
Baltimore, Maryland, 21205
Email: pdavidson@jhu.edu

Previous presentation:
Hansen, B.R., Koirala, B., Beaman, A., & Davidson, P.M. (2018). Point prevalence studies on
delirium: A systematic review. Paper presented at the 8th American Delirium Society Annual
Conference, San Francisco, California.

Authors Contribution Statement:
BK, BH, AB and PD conceptualized this manuscript. BK, BH and SS performed literature
search. BK, BH screened studies and performed data extraction. BK, CB performed metaanalysis and interpretation. BK, BH, PD and AH made material contribution in terms of
developing the construct and making substantial editorial contribution. All co-authors critically
reviewed the manuscript and approved final version for submission.

No disclosures to Report

Delirium Point Prevalence Studies in Inpatient Settings: A Systematic Review and MetaAnalysis

Abstract
Aims: To examine the delirium point prevalence studies conducted in different inpatient
settings and to discuss the implication of the findings for delirium screening, assessment,
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prevention, and management.
Background: Delirium—a common and distressing condition manifesting as an acute decline
of attention and cognition—is frequently overlooked, misdiagnosed or treated inappropriately.
This neuropsychiatric syndrome manifests as changes in attention, cognition, and awareness,
with a resultant impact on behavior, function, and emotions. Delirium is recognized as a
patient management challenge in the inpatient setting and there is a need to understand the
current point prevalence and assessment practices of delirium.
Design: A systematic review and meta-analysis
Methods: A systematic review of published delirium prevalence studies in inpatient settings
was conducted and the implications of findings for delirium screening, assessment, prevention,
and management identified. The random-effects meta-analysis was conducted among studies
measuring delirium point prevalence. The PRISMA statement was used to report systematic
review and meta-analysis.
Results: Nine studies were included in the review, with sample sizes ranging from 47 to 1867.
Delirium point prevalence ranged from 9% to 32%. Hypoactive delirium was the most
common subtype, ranging from 23% to 78%. Fifteen delirium screening tools or assessment or
diagnostic methods were used. Comorbid dementia was present in up to 50% of inpatients.
Conclusions: Gaining a consensus on effective delirium instruments, the time windows for
assessment and measurement will be crucial in driving benchmarking and quality improvement
studies.
Relevance to clinical practice: Consistent identification of high-risk patients and treatment
settings with elevated risk, accompanied by the implementation of effective preventive and
management strategies, are critical to addressing delirium— a frequent and burdensome
condition, that adversely affects patient outcomes.
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Introduction
Delirium is a neuropsychiatric syndrome that manifests as an acute decline of attention
and cognition and occurs across healthcare settings (European Delirium Association &
American Delirium Society, 2014; National Institute for Health and Care Excellence, 2010).
The healthcare costs of delirium are considerable: 182 billion Euros per year in Europe and
164 billion dollars in the United States (Bellelli et al., 2016). Delirium occurs suddenly,
usually after exposure to an acute stressor, such as sepsis, surgery, administration of
medications with anticholinergic effects or prolonged periods of immobility (American
Psychiatric Association, 2013). Given sufficient physiological stressors, delirium can occur in
people of any age; however, it is more common in older adults who have experienced major
illness or surgery, especially involving an intensive care stay (Devlin et al., 2018). At least
20% of older hospitalized inpatients (Ryan et al., 2013) and up to 80% of patients in intensive
care units are affected by delirium (Richardson et al., 2017). Delirium can last from hours to
many weeks before resolving (Kolanowski, 2018) or—for a significant proportion of the
population—may last a long time and never return to pre-hospitalization baseline.
Delirium impacts the patients’ communication abilities, decision-making, functional
capacity and quality of life (Logan, 2018). Patients recovering from an episode of delirium and
their family members generally recall the experience as humiliating and frightening (O'Malley,
Leonard, Meagher, & O'Keeffe, 2008). Behavioral symptoms of delirium, commonly and
imprecisely referred to as terminal restlessness or terminal agitation, can also cause distress for
caregivers (Finucane, Lugton, Kennedy, & Spiller, 2017). In addition, delirium is associated
with worsening functional independence, longer hospital stays, and higher mortality rates
(Bellelli et al., 2016; Pandharipande et al., 2017). Recent literature indicates that delirium is a
strong predictor of cognitive decline and dementia in older people (Davis, Muniz-Terrera, &
Keage, 2017), consistently occurring after any hospitalization in which delirium occured,
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including patients who are postoperative or were in critical care (Pandharipande et al., 2013),
in a long-term care settings, and in the community (Davis et al., 2014).
Despite the burden, delirium is often unrecognized and undiagnosed, resulting in
inadequate care, treatment, and adverse health outcomes (Pandharipande et al., 2017). Delirium
has multiple precipitating factors, occurs in a variety of settings such as home, long-term care,
acute care, and intensive care, and the baseline cognitive status of patients who develop this
neuropsychiatric syndrome is often unknown or unclear (Marra et al., 2019). The recognition
of delirium characteristics, and optimizing clinical management, continue to pose a challenge
for healthcare providers. Thus, the need for identification, appropriate prevention, and
management strategies of delirium is increasingly receiving the attention of researchers and
healthcare providers alike as a major public health priority (Salluh et al., 2015).
Evidence for the identification, management and support for delirium is evolving but
needs further development. Previous reviews on delirium have underscored delirium
prevalence, incidence, and outcomes for patients in intensive care units (Krewulak, Stelfox,
Leigh, Ely, & Fiest, 2018; Salluh et al., 2015), palliative care inpatient settings (Hosie,
Davidson, Agar, Sanderson, & Phillips, 2013) and post-acute and long-term care settings
(Forsberg, 2017). However, no review has explicitly examined delirium point prevalence
studies and identification methods across inpatient settings, nor discussed the implication of
the findings for delirium screening, assessment, prevention, and management. Point prevalence
is based on an examination at a given point in time, which reflects current estimates of disease
frequency or burden (Hunter & Risebro, 2011) and has implications for practice. Though
systematic identification methods help improve recognition of delirium, they are not routinely
conducted across healthcare settings (Marra et al., 2019). Developing a clearer understanding
of point prevalence and screening practices across inpatient settings will help inform the
significance of the problem and highlight areas of need supporting improvement efforts to
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effectively prevent, identify, and manage delirium.
Aim
To examine the delirium point prevalence studies conducted in different inpatient settings and
discuss the implication of the findings for delirium screening, assessment, prevention, and
management.
Methods
Design
This systematic review and meta-analysis was guided and reported using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (see
Supplementary File 1; Moher, Liberati, Tetzlaff, & Altman, 2009).
Search method
The search strategy was guided by an experienced health librarian and used PubMed,
Embase, Scopus, and CINAHL databases. Two stages of the search were performed using
Medical Subject Headings (MeSH) and keywords, along with their associated derivatives. The
first search was specific to delirium point prevalence among the elderly in a hospital or acute
care settings. The second search was broader and without any keywords related to location to
capture all the relevant studies for the review. Search terms were: "Delirium" OR "delirium"
OR "delirious" OR "delirious" AND "point prevalence" OR "point NEAR/3 Prevalen*" AND
"adult" OR "aged" OR "elder" OR "senior" or "older" or "frail" OR "geriatric". To specify a
specific location in the first search stage, the search terms used were: "hospitals" OR "hospital"
OR "Hospital*" "acute". In addition to the database search, hand searching, and reference lists
of included studies and relevant reviews were also examined to find potentially relevant
papers. In the initial search, studies undertaken between 1986 and 2017 were included.
Additional hand searches, searching of the relevant studies through Google, Google Scholar,
databases other than the included and reference lists of previous studies, were conducted in
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February 2019 and June 2019 to determine whether other recent eligible delirium point
prevalence studies met the inclusion criteria.
Study selection and data extraction
The criteria for inclusion were papers published in English reporting delirium point
prevalence in adult participants (18 years of age or older) in inpatient settings (i.e., hospitals or
acute care settings). The search resulted in a total of 193 papers, which were reduced to 66
after deleting duplicates. Authors examined titles and abstracts of 66 papers to determine
whether they were relevant to include in the study. Twenty-four papers were excluded after
title and abstract review, with 42 papers identified for full-text review. Study screening was
completed by the first two authors independently, with final inclusion determined after
consultation with senior authors. Nine studies were selected for inclusion. The PRISMA flow
diagram is presented in Figure 1.
The final selected studies were reviewed by two authors to evaluate the delirium point
prevalence, delirium screening tools, and additional findings on types of delirium, screening
practices, and dementia comorbidities.
Data analysis
Meta-analysis of delirium point prevalence was conducted using comprehensive metaanalysis software. Studies with two or more measurements of delirium were included in the
meta-analysis with point prevalence that was measured using the Diagnostic and Statistical
Manual of Mental Disorder (DSM) criteria. Heterogeneity (Q-test) with I squared (I2) statistics
were measured and helped decide on the random-effects model for the study (Riley, Higgins,
& Deeks, 2011). Further, analysis estimated Tau squared (τ2) (using the DerSimonian and
Laird method) and produced a funnel plot to assess publication bias.
Results
Among the nine point-prevalence studies included in the review, the majority were
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performed in a single country: Australia (Casey et al., 2019; Hosie et al., 2016), Denmark
(Norbaek & Glipstrup, 2016), Ireland (Ryan et al., 2013), Italy (Bellelli et al., 2016), Scotland
(Spiller & Keen, 2006), and UK (Giraud & Vuylsteke, 2014). One study (Elliott et al., 2013)
included two countries: Australia and New Zealand; one study (Salluh et al., 2010) included 11
countries: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Spain, USA,
and Uruguay. All studies focused on inpatient settings: ICU (n=3) (Elliott et al., 2013; Giraud
& Vuylsteke, 2014; Salluh et al., 2010); acute care hospital (n=4) (Bellelli et al., 2016; Casey
et al., 2019; Norbaek & Glipstrup, 2016; Ryan et al., 2013); palliative care unit or hospice
(n=2) (Hosie et al., 2016; Spiller & Keen, 2006). The sample size for the selected studies
ranged from 47 to 1,867 participants: who were primarily older adults with a reported mean
age range of 61-82 years and 42-63% male. Information on setting, sample size, population
characteristics, delirium screening tools, and point prevalence results were extracted and are
presented in Table 1.
Delirium screening tools
Fifteen different screening, assessment, or diagnostic methods were used to identify
delirium (Table 2). The Diagnostic and Statistical Manual of Mental Disorders criteria for
delirium, DSM-5 (Hosie et al., 2016) and DSM-IV (Norbaek & Glipstrup, 2016; Ryan et al.,
2013) were commonly used to assess delirium. The next most frequently used tools were: the
Confusion Assessment Method (CAM) (Ryan et al., 2013; Spiller & Keen, 2006); the 4A
Test—screening instrument for cognitive impairment and delirium (Bellelli et al., 2016; Casey
et al., 2019); the Confusion Assessment Method for the ICU (CAM-ICU) (Giraud &
Vuylsteke, 2014; Salluh et al., 2010); the 3-Minute Diagnostic Interview for the Confusion
Assessment Method (3D-CAM) (Casey et al., 2019); Brief Confusion Assessment Method
(bCAM) (Norbaek & Glipstrup, 2016); Clinical Assessment (Elliott et al., 2013); Delirium
Rating Scale-Revised-98 (DRS-R98), (Ryan et al., 2013); Delirium-specific ICD codes (F05.0,
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F05.1, F05.8, F05.9) (Casey et al., 2019); Intensive Care Delirium Screening Checklist
(ICDSC) (Elliott et al., 2013); Spatial Span Forwards (SSF), counting backwards from 20 was
used for visually-impaired patients (Ryan et al., 2013); Months Backwards (MB), adapted from
the Short Blessed Test for dementia (Ryan et al., 2013); Nursing Delirium Screening Scale
(Nu-DESC) (Hosie et al., 2016) and other (Elliott et al., 2013). Two assessment tools were
used to identify delirium subtype— Memorial Delirium Assessment Scale (MDAS) (Hosie et
al., 2016; Spiller & Keen, 2006) and Delirium Motor Subtype Scale (DMSS) (Bellelli et al.,
2016). Seven studies used multiple assessment methods.
Delirium point prevalence
The delirium point prevalence ranged from 9% to 34%. The time periods used to
measure point prevalence varied—one day (n=4) (Bellelli et al., 2016; Casey et al., 2019; Ryan
et al., 2013; Salluh et al., 2010); two non-consecutive days (n=2) (Hosie et al., 2016; Norbaek
& Glipstrup, 2016); two consecutive days (n=2) (Casey et al., 2019; Spiller & Keen, 2006);
three non-consecutive days (n=1) (Elliott et al., 2013); and seven days (n=1) (Giraud &
Vuylsteke, 2014).
Meta-analysis findings on delirium point prevalence
The findings from meta-analysis with forest plot is presented in Table 3. The study
estimated τ2 (using the DerSimonian and Laird method) to be 0.162. The Q-test of
heterogeneity was statistically significant (Q=79.894, p<0.001) and the I2 was also high (90%);
both measures suggested presence of substantial heterogeneity. Hence, we used the randomeffects model using delirium prevalence as an outcome, and a meta-analysis estimate of
prevalence was 22.3%, with a 95% prediction interval of (17.8%, 27.7%). The funnel plot
suggested some evidence of publication bias.
Additional results
These studies highlighted the issue of under-screening and as a consequence under-
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reported delirium. In one study, only 3% of participants were assessed for delirium as part of
routine clinical practice (Elliott et al., 2013). Of the participants who screened positive with
delirium in another two studies, less than half had the diagnosis documented in their medical
records (Casey et al., 2019; Norbaek & Glipstrup, 2016). One study reported that delirium was
associated with increased ICU and hospital mortality and longer duration of hospitalization
(Salluh et al., 2010). The motoric, or repetitive muscle movement, delirium subtype was
identified in 64.1% of the delirium patients. Hypoactive delirium was most common (23-78%),
followed by mixed delirium (4.6-27.3%), and hyperactive delirium (1.8-21.5%). Non-motoric
delirium was identified least commonly (12.7%) (Bellelli et al., 2006). Comorbid dementia
was identified in about half (50.9% and 52.9%) of identified delirium cases in two studies
(Bellelli et al., 2016; Ryan et al., 2013).
Discussion
This review identified that delirium point prevalence ranged from 9% to 32% in
inpatient settings. The included studies were characterized by diversity and heterogeneity in
populations and instruments and signaled the need for obtaining consensus on a range of
issues, including screening and assessment tools appropriate for inpatient settings. These
results have important implications for the development of guidelines and models of care.
Although time periods included within the measurement window of this review varied,
each of the included studies used the estimate of point prevalence. In the literature, some
studies defined point prevalence and period prevalence similarly; however, a distinction can
also be made between these two approaches to prevalence measurement. The proportion of a
population who have specific characteristics at a specific point in time is point prevalence,
whereas, the proportion of a population who have specific characteristics at any point in time
during a given period of interest is a period prevalence, with “past 12 months” being a
commonly used period prevalence time span (National Institute of Mental Health, 2017). The
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delirium literature more often uses period prevalence as opposed to point prevalence. Point
prevalence provides more contemporary estimates for burden of disease (Ward, 2013). The
identification of point estimates of delirium in inpatient setting is crucial to increase awareness
concerning this condition among healthcare providers and administrators, driving the
implementation of delirium prevention and management programs.
One of the key findings of this review is that delirium point prevalence was fairly stable
and consistent across the time periods, clinical settings and countries of these studies. This may
suggest that there is commonality in patients’ risk across inpatient settings of care. This is not a
novel observation, but it underscores the need to consider consolidated care systems for
delirium across hospitals. For example, prevention interventions addressing fundamental
human needs have been found to be effective for older patients across a range on inpatient
settings (Hshieh et al., 2015; Pun et al., 2019; Siddiqi et al., 2016). A meta-analysis on the
impact of 11 studies on delirium prevention with multi-component non-pharmacological
interventions found, >50% odds reduction (OR=0.47, 95% CI, 0.38–0.58) in occurrence of
delirium during hospitalization (Hshieh et al., 2015). In addition, outpatient models of care,
such as Hospital-at-Home, which have consistently demonstrated good patient outcomes and
cost-effectiveness, may be an approach to care delivery that can decrease the risk of delirium
(Caplan, 2008; Conley, O’brien, Leff, Bolen, & Zulman, 2016; Shepperd et al., 2016).
Since delirium is often under-screened, under-recognized and under-reported, this and
previous reviews highlight the need to identify an appropriate delirium screening tool for
timely recognition (Watt et al., 2019). Further, there is a need to evaluate delirium
identification strategies across inpatient settings. A study of the utility of delirium screening
and diagnostic tools across settings would not only help reach consensus on delirium
identification processes but also develop clinical practice guidelines for early detection of
delirium (Lawlor & Bush, 2014; Watt et al., 2019). Obtaining consensus on delirium
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identification is also needed for study comparison and data harmonization (Neufeld et al.,
2014).
This review found that hypoactive delirium was the most commonly identified sub-type
(Martins & Fernandes, 2012) and was also the most likely to be under-recognized (Marra et al.,
2019). This is important to consider as hypoactive delirium has been associated with poor
outcomes including longer lengths of stay and mortality (Peritogiannis, Bolosi, Lixouriotis, &
Rizos, 2015; Robinson, Raeburn, Tran, Brenner, & Moss, 2011). Another important
observation of this review was the high rates of documented co-morbid dementia in
participants with delirium. The prevalence of delirium superimposed on dementia ranges from
22 to 89%, with the high prevalence among those who are hospitalized (Davis et al., 2015;
Grossi et al., 2019). This review and other studies highlight the importance of guidelinedirected assessment for delirium, identification of high risk groups, and preventive strategies
(Devlin et al., 2018). The association between immobility, lack of sleep and delirium are
important issues to consider, particularly in critical care units.

Strengths and Limitations
This study has several limitations. First, the review included only papers published in English.
Second, although this appraisal focused on the inpatient setting, a diversity of populations and
assessment methods make it harder to make definitive recommendations. The non-inclusion of
community setting delirium point prevalence studies is a limitation of this review. The study
analysis produced a funnel plot (Figure 2), and there appears to be some publication bias;
however, the number of studies was small to make a comprehensive assessment of publication
bias.
Despite the limitations, this review has identified important issues for consideration,
such as the critical need to standardize the timing and the assessment instruments for delirium
both in clinical practice and research. Further, this review reinforced standard care
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recommendations for care providers and nurses on early diagnosis and management of
delirium. Standardization of delirium assessment and widespread adoption of intervention
recommendations are important to promote optimum patient outcomes in inpatient settings,
especially in the context of a steady global increase in population age, multi-morbidity, and
healthcare complexities.
Conclusions
In the studies reviewed, up to a third of adults in inpatient settings were identified as
delirious during the assessment time windows with hypoactive delirium being the most
prevalent. As part of the increasing focus on delirium reduction it will be important to develop
both research and clinical consensus on the best approach to delirium screening and assessment
as an important step toward effective, systematic, and widely disseminated delirium
intervention implementation.

Relevance to clinical practice
As populations age and the risk for delirium increases, the importance of age-friendly
environments, caregiver engagement, and close attention to the known precipitants of
delirium— especially in high-risk populations—is underscored. Multimorbidity, or the
presence of two or more long term chronic conditions, is another factor that frequently
increases with age and contributes to the risk for the development of delirium (Yarnall et al.,
2017). As these factors comprise the composite picture of many individuals in inpatient
settings, health systems should refocus and recalibrate care to address these specific needs.
Young and Inouye (2007) comment that delirium could be prevented with better systems of
routine care in least a third of patients (Young & Inouye, 2007). Consistent identification of
high-risk patients and treatment settings with elevated risk, accompanied by implementation of
effective preventive and management strategies, are critical to addressing this frequent and

DELIRIUM POINT PREVALENCE: REVIEW & META-ANALYSIS

16

burdensome condition that adversely affects patient outcomes. Given the results of the present
review and delirium clinical care standards (Australian Commission on Safety and Quality in
Health Care, 2016), the recommendations for basic elements of delirium care for patients in
inpatient settings are as follows:
-

Early screening: Health care organizations and care providers, including nurses, should
focus on routine screening of cognitive function for patients at risk of delirium using
appropriate and validated screening tools. Additionally, patients and caregivers should be
asked to report any recent changes in a patient’s behavior and thinking for early detection
of delirium.

-

Assessment of delirium: If the presence of delirium is suspected, prompt patient assessment
should be completed by physicians and nurses who are trained and competent in delirium
diagnosis, using validated diagnostic tools.

-

Intervention to prevent and manage delirium: Provide patients who are at risk of or with
delirium a set of interventions to prevent delirium and involve their caregivers. Potential
interventions that can be initiated by nurses and other care providers include medication
review, mobility exercises, oxygen therapy, correction of dehydration, malnutrition, and
constipation, pain assessment and management, cognition stimulating activities,
reassurance and reorientation, and sleep promotion.

-

Prevention of potential harm: If a patient is diagnosed with delirium, assess, monitor and
document the patient’s risk of developing pressure injury and having a fall. Further,
implement appropriate interventions with both patient and caregivers that are tailored to the
assessment findings.

-

Minimize the use of antipsychotic drugs: Non-pharmacological interventions are the firstline interventions for both prevention and treatment of delirium (Hshieh, Inouye, & Oh,
2018). Treat patients with delirium with antipsychotic drugs only if the patient is distressed
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and the cause of distress cannot be addressed or when non-pharmacological interventions
have failed to ease the symptoms.
-

Transition from hospital: Develop and provide an individualized care plan for patients with
current or resolved delirium before discharge. Involve patients and caregivers in
developing these plans and educate them about delirium.
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What does this paper contribute to the wider global clinical community?
-

This review identified delirium point prevalence of 9% to 32.2% in inpatient settings, with
hypoactive delirium being the most prevalent.

-

Comorbid dementia was present in about half of delirium cases underscoring the complexity
of diagnosis and the presence of multi-morbidity.

-

Fifteen different screening, assessment, or diagnostic methods were used to identify delirium
in inpatient settings. Gaining consensus on delirium instruments, time windows for
assessment and measurement will be critical for research and practice.
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Table 1. Summary of studies included
Author
(s), Year

Country

Setting

Population
(sample
size,
population
rate)

Sample
characteristics
Age (Mean ±
SD/ Median
[IQR]);
Male (%)
73.0 ± 16.4
45% male

Diagnostic
criteria for
point
prevalence

Point prevalence =
Patients with delirium
/sample size = x/n (%)

Time
period

Other findings

Casey et
al., 2019

Australia

Australian
Health Service
including 5
hospitals and
25 inpatient
wards

n = 559
(aged 18
years and
older)

4AT,
3D-CAM,
ICD codes

91/559 (16.3)

One day for
four
hospitals
and two
days for one
large
hospital

n = 1867
(aged 65
years or
more)

82.0 ± 7.5
years
42% male

4AT,
DMSS

429/1867 (22.9)

One day

2 palliative care
units

n = 47

74 ± 10 years
60% male

Nu-DESC,
MDAS,
DSM 5

16/47 (34) screened positive
& 9/47 (19) met DSM-5
diagnostic criteria

Denmark

Acute hospital

n = 118

Age over 65
years
43% male

bCAM,
DSM-IV

38/118 (32)

UK

9 intensive care
units

n = 217

-

CAM-ICU

63/217 (29)

Two nonconsecutive
days
(24-hours
period)
Two nonconsecutive
days
(3-hours
period)
One week

Only 58/559
participants (10.4%)
had ICD delirium
codes recorded in their
medical record. Of
participants with
confirmed delirium,
only 31/91 (34.1%)
had ICD delirium
codes assigned.
The most common
delirium subtype
observed was
hypoactive followed
by mixed,
hyperactive, and nonmotoric. Among those
identified with
delirium, 227/429
(52.9%) also had
dementia.
Only 2/16 (12.5%) of
participants could be
assessed using the
MDAS.

Bellelli et
al., 2016

Italy

Multicenter:
108 acute care;
12
rehabilitation
wards

Hosie et
al., 2016

Australia

Norbaek &
Glipstrup.,
2016
Giraud &
Vuylsteke.,
2014

Among patients with
delirium only 18/38
(47%) had a diagnosis
documented in their
medical charts.
If delirium was
previously diagnosed,
routine screening of
delirium was
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Elliott et
al., 2013

Australia
& New
Zealand

41 intensive
care units:
Australia= 36;
New Zealand=
5

n = 428
(lightly
sedated to
very
agitated
patients)

62 (48-72)
years
63% male

ICDSC,
Clinical
Assessment,
Other

40/428 (9)

Three days,
nonconsecutive
(4-hours
period)

Ryan et al.,
2013

Ireland

Tertiary care
teaching
hospital

n = 311

69 (17-100)
years
48.9% male

SSF,
MB,
CAM,
DRS-R98,
DSM-IV

CAM: 52/296 (17.6)
DSM IV: 55/280 (19.6)
DRS-R98: 58/280 (20.7) full
delirium, & 24/280 (8.6)
subsyndromal delirium

One day

Salluh et
al., 2010

11
countries
from South
America,
North
America &
Spain

104 intensive
care units

n = 497

62 (47-74)
years
52.5% male

CAM-ICU

75/232 (32.2); after
excluding deeply sedated
and unarousable patients

One day

Spiller &
Keen,
2006

Scotland

8 specialist
palliative care
units

n = 109

Mean age
ranged from
63.7 to 82.8
years in 8
specialist
palliative care
units

CAM,
MDAS

32/109 (29.4)

Two days
consecutive

conducted on 170/208
(82%) of bed-days. If
no previous delirium
diagnosis, routine
assessment was
conducted 270/552
(52%) of bed-days.
Only 19/569 (3%) of
the participants were
routinely assessed for
delirium across all
units on the respective
study days in which
they participated.
Among those
diagnosed with
delirium using DSMIV criteria, 28/55
(50.9%) patients had
pre-existing dementia
that was poorly
documented in
medical record.
Delirium was an
independent predictor
of intensive care unit
and hospital mortality
and was also
associated with longer
duration of
hospitalization.
Among patients with
delirium, 25/32 (78%)
had hypoactive
delirium, (5/32) 16%
had mixed, and 2/32
(6%) had hyperactive.

DSM: Diagnostic and Statistical Manual of Mental Disorders; CAM: Confusion Assessment Method; CAM-ICU: Confusion Assessment Method for the Intensive Care Unit; MDAS: Memorial Delirium Assessment Scale; 4AT:
4A Test; 3D-CAM; 3-Minute Diagnostic Interview for the Confusion Assessment Method; bCAM: Brief Confusion Assessment Method; DMSS: Delirium Motor Subtype Scale; DRS-R98: Delirium Rating Scale-Revised-98; ICD:
Internationa Classification of Disease; ICDSC: Intensive Care Delirium Screening Checklist; IQR: Interquartile Range; MB: Months Backwards; Nu-DESC: Nursing Delirium Screening Scale; SSF: Spatial Span Forwards
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Table 2. Delirium screening, assessment or diagnostic tools used in included studies

Delirium Screening/Assessment Tools

No. of studies used

Diagnostic and Statistical Manual of Mental Disorders (DSM)

3

Confusion Assessment Method (CAM)

2

Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

2

Memorial Delirium Assessment Scale (MDAS)

2

The 4A Test: screening instrument for cognitive impairment and delirium

2

3-Minute Diagnostic Interview for the Confusion Assessment Method (3D-CAM)

1

Brief Confusion Assessment Method (bCAM)

1

Clinical Assessment

1

Delirium Motor Subtype Scale (DMSS)

1

Delirium Rating Scale-Revised-98 (DRS-R98)

1

Delirium-specific Internationa Classification of Disease (ICD) codes (F05.0, F05.1, F05.8, F05.9)

1

Intensive Care Delirium Screening Checklist (ICDSC)

1

Months Backwards (MB), adapted from the Short-Blessed Test for dementia

1

Nursing Delirium Screening Scale (Nu-DESC)

1

Spatial Span Forwards (SSF),

1

-

Counting backwards from 20 was used for visually-impaired patients

Other (not specified in the study)

1
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Table 3. Meta-analysis results on delirium point prevalence

Study name

Statistics for each study

Event rate and 95% CI

Event Lower Upper
rate limit limit Z-Value p-Value
Casey et al., 2019
Bellelli et al., 2016
Hosie et al., 2016
Norbaek & Glipstrup, 2016
Giraud & Vuylsteke, 2014
Elliott et al., 2013
Ryan et al., 2013
Salluh et al., 2010
Spiller & Keen, 2006

0.163
0.230
0.191
0.322
0.290
0.093
0.196
0.323
0.294
0.223

0.134
0.211
0.103
0.244
0.234
0.069
0.154
0.266
0.216
0.178

0.196
0.249
0.329
0.411
0.354
0.125
0.247
0.386
0.386
0.277

-14.294
-21.987
-3.885
-3.779
-5.977
-13.682
-9.366
-5.263
-4.175
-8.498

0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
0.000
-1.00

-0.50

0.00

0.50

1.00
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Figure 2: Funnel plot of standard error by logit event rate

